Skip to main navigation Skip to search Skip to main content

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension

  • Lianne M Geerdink
  • , Harald Bertram
  • , Georg Hansmann

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science